Scholars Central

OpinionPublished 30 Sep 2022

Antithrombin deficiency

Authors: Andriya Collins

Journal of Blood Disorders and Treatment

Volume 5 · Issue 5 · Pages 05

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Antithrombin (AT; Antithrombin III) deficiency is described as an AT activity level that is consistently less than 80% of normal (or the lower limit of the assay's reference range). It can be inherited or acquired. Some patients may experience a higher chance of thromboembolism due to AT deficiency. Replacement therapy is now feasible thanks to the availability of plasma-derived AT concentrates and recombinant AT, but their authorised use is only for people who have hereditary AT deficiency.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Blood Disorders and Treatment.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Blood Disorders and Treatment
  • SubjectHaematology
  • BylineArticles whose byline prints “Andriya Collins”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels